These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 29206243)
41. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. Davis MP Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296 [TBL] [Abstract][Full Text] [Related]
42. Peripherally Administered Y Ailanen L; Vähätalo LH; Salomäki-Myftari H; Mäkelä S; Orpana W; Ruohonen ST; Savontaus E Front Pharmacol; 2018; 9():319. PubMed ID: 29674968 [TBL] [Abstract][Full Text] [Related]
43. A new perspective of cannabinoid 1 receptor antagonists: approaches toward peripheral CB1R blockers without crossing the blood-brain barrier. Wu YK; Yeh CF; Ly TW; Hung MS Curr Top Med Chem; 2011; 11(12):1421-9. PubMed ID: 21510837 [TBL] [Abstract][Full Text] [Related]
44. The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice. Giné E; Echeverry-Alzate V; Lopez-Moreno JA; Rodriguez de Fonseca F; Perez-Castillo A; Santos A Neuropharmacology; 2017 Apr; 116():132-141. PubMed ID: 28017790 [TBL] [Abstract][Full Text] [Related]
56. Tetrahydropyrazolo[4,3-c]pyridine derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists. Zhu B; Matthews JM; Xia M; Black S; Chen C; Hou C; Liang Y; Tang Y; Macielag MJ Bioorg Med Chem Lett; 2016 Nov; 26(22):5597-5601. PubMed ID: 27671499 [TBL] [Abstract][Full Text] [Related]
57. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity. Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930 [TBL] [Abstract][Full Text] [Related]
58. Weight loss induced by rimonabant is associated with an altered leptin expression and hypothalamic leptin signaling in diet-induced obese mice. Lazzari P; Sanna A; Mastinu A; Cabasino S; Manca I; Pani L Behav Brain Res; 2011 Mar; 217(2):432-8. PubMed ID: 21074566 [TBL] [Abstract][Full Text] [Related]
59. The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice. Micale V; Drago F; Noerregaard PK; Elling CE; Wotjak CT Front Pharmacol; 2019; 10():207. PubMed ID: 30949045 [TBL] [Abstract][Full Text] [Related]
60. Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus. Zhang J; Wang N; Chen B; Wang Y; He J; Cai X; Zhang H; Wei S; Li S Neurosci Lett; 2016 Sep; 630():70-76. PubMed ID: 27461790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]